Answers are grounded in this paper and cite their sources.
This article examines whether membership in the MASI ESG, Africa's first ESG stock market index, expanded to include twenty companies in November 2023, translates into superior risk-adjusted performance for companies listed on the Casablanca Stock Exchange. Using a matched sample of 39 listed companies and firm-period observations from November 2023 to April 2026, the study estimates pooled OLS models with robust standard errors to examine the association between MASI ESG membership and risk-adjusted stock performance, using the annualized Sharpe ratio as the dependent variable and a binary ESG indicator as the variable of interest. The results show that the coefficient associated with MASI ESG membership is negative ( between −0.24 and −0.35) but not statistically significant across all specifications (p > 0.20), even after controlling for sector and time effects. These results, robust to various mean difference tests, are primarily explained by the cyclical outperformance of non-ESG sectors, the real estate and mining sectors over the period, as well as by the short observation window. This study contributes to the growing literature on emerging markets by documenting the absence of a short-term ESG premium in the Moroccan context and formulates methodological recommendations for future research.
No takes yet. Share an insight, caveat, or question.
Bazi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: